| Steven Mitchell Dierking, | |
|
1014 Pacific Grove Ln Apt 2, Pacific Grove, CA 93950-3857 | |
| (623) 340-5235 | |
| Not Available |
| Full Name | Steven Mitchell Dierking |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1014 Pacific Grove Ln Apt 2, Pacific Grove, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326601188 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 79883 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Steven Mitchell Dierking, 1014 Pacific Grove Ln Apt 2, Pacific Grove, CA 93950-3857 Ph: () - | Steven Mitchell Dierking, 1014 Pacific Grove Ln Apt 2, Pacific Grove, CA 93950-3857 Ph: (623) 340-5235 |
News Archive
A team of U.S., Canadian and Italian scientists led by researchers at Johns Hopkins report evidence from studies in animals and humans supporting a link between Alzheimer's disease and chronic heart failure, two of the 10 leading causes of death in the United States.
The Centers for Medicare & Medicaid Services today proposed new rules for hospitals that would protect patients' rights to choose their own visitors during a hospital stay, including visitors who are same-sex domestic partners.
The Center for Global Health Policy's "Science Speaks" blog examines a recent study that found only slightly more than 44 percent of women in the Nyanza province of Kenya deliver their infants in a health care facility, with many women citing fear of stigma and discrimination as a reason for not attending clinics for prenatal care.
Researchers at The University of Texas M. D. Anderson Cancer Center say they have jumped a significant hurdle in the use of RNA interference (RNAi), believed by many to be the ultimate tool to both decode the function of individual genes in the human genome and to treat disease.
The U.S. Food and Drug Administration today approved Adynovate, Antihemophilic Factor (Recombinant), PEGylated for use in adults and adolescents, aged 12 years and older, who have Hemophilia A. Adynovate is modified to last longer in the blood and potentially require less frequent injections than unmodified Antihemophilic Factor when used to reduce the frequency of bleeding.
› Verified 4 days ago
Dr. Deborah Gail Bille, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 802 Todd Lane, Pacific Grove, CA 93950 Phone: 831-917-9425 | |
Dr. Dana J Gordon, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 133 15th St, Pacific Grove, CA 93950 Phone: 831-373-1225 Fax: 831-373-3705 | |
Dr. Jesseca Lauren Pennoyer, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 160 Country Club Gate Ctr, Pacific Grove, CA 93950 Phone: 831-373-8323 | |
Kenneth Bear, PHARMACIST Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 133 15th St, Pacific Grove, CA 93950 Phone: 831-373-1225 | |
Johannes Hermanus Maartens, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 160 Country Club Gate Ctr, Pacific Grove, CA 93950 Phone: 831-373-8323 | |
Emily Cushman, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1212 Forest Ave, Pacific Grove, CA 93950 Phone: 831-375-3019 |